{"entities":{"Q91855":{"pageid":93145,"ns":120,"title":"Item:Q91855","lastrevid":84599894,"modified":"2026-05-26T20:45:27Z","type":"item","id":"Q91855","labels":{"en":{"language":"en","value":"Optimal two-stage designs for phase II clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91855$13DF1FF0-2287-4894-9E8F-6D75D0C47B49","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"d5563128a3eb17b6f30c0f80cffe0b52cce78dc5","datavalue":{"value":"10.1016/0197-2456(89)90015-9","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q91855$D1A23CEF-9078-47D7-BFE7-6B3CA4DAFAA7","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"a31ad642f0d347c42266634c66f56e4b5181049a","datavalue":{"value":{"entity-type":"item","numeric-id":60781,"id":"Q60781"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91855$DE3A20C2-DD31-48B2-908A-54F6017F57EC","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"5b0bcece43c663d323049deacb7aea2424d7712b","datavalue":{"value":"10","type":"string"},"datatype":"string"},"type":"statement","id":"Q91855$7BDB333F-C90D-499C-8507-9FF81B4D3B2B","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"68b47585e633a4a2b067e511536f1dd047cbde8f","datavalue":{"value":"1","type":"string"},"datatype":"string"},"type":"statement","id":"Q91855$841426CD-D074-4E96-A818-9247967DF2C9","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"311d9233b799f854ef2dec4849d215a2c1234e3e","datavalue":{"value":"1-10","type":"string"},"datatype":"string"},"type":"statement","id":"Q91855$4BB35B0D-3A78-4562-A682-BC8C3E975353","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"13e9eb3466a6eab675aba9c11570be8326febf20","datavalue":{"value":{"time":"+1989-03-00T00:00:00Z","timezone":0,"before":0,"after":0,"precision":10,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q91855$160B125E-8E0D-4097-8A1A-F506651419EE","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"f95382ae3b619a13e3a47ba8798cf31b7c809628","datavalue":{"value":"Q46412217","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q91855$04B6CDC7-83C3-4DB9-8A50-D89040BB78FA","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91855$E9C5E738-63A5-46C7-A9D5-6C0FDF05C5CA","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"5565072470ffe8f6ccb2ec086e663053f6035213","datavalue":{"value":"Richard Simon","type":"string"},"datatype":"string"},"type":"statement","id":"Q91855$44EE8738-7B5F-4090-A53C-2681893FEEC9","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Optimal two-stage designs for phase II clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Optimal_two-stage_designs_for_phase_II_clinical_trials"}}}}}